US Stock MarketDetailed Quotes

TCBP TC BioPharm

Watchlist
  • 1.0701
  • -0.0499-4.46%
Trading Jun 13 15:10 ET
5.29MMarket Cap-55P/E (TTM)

TC BioPharm Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
17.27%-2.41M
31.04%-10.54M
-3.64M
-2.91M
-174.01%-15.29M
-62.62%-5.58M
-67.45%-2.55M
-1.09M
49.00%-3.43M
-1.52M
Net income from continuing operations
-423.20%-3.32M
-349.68%-5.91M
--288.49K
---634.91K
91.23%-1.31M
-126.00%-14.98M
-168.52%-4.52M
---7.3M
3.83%-6.63M
---1.68M
Operating gains losses
99.64%-11.45K
49.97%-7.97M
---4.96M
---3.17M
-475.26%-15.94M
224,465.20%4.25M
45,841.19%271.05K
--3.97M
-97.40%1.89K
--590
Depreciation and amortization
-29.81%127.02K
-17.75%633.01K
--258.81K
--180.97K
-24.92%769.6K
-4.66%1.03M
-6.78%250.35K
--249.31K
18.88%1.08M
--268.56K
Other non cash items
----
-89.40%717.41K
--557.57K
--231.54K
96.85%6.77M
1,081.49%3.44M
2,692.96%1.92M
--1.15M
14.80%291.03K
--68.81K
Change In working capital
-96.11%13.13K
122.96%1.54M
--307.02K
--337.21K
-2,789.09%-6.7M
-402.61%-232.08K
14.28%-410.55K
---270.81K
104.23%76.69K
---478.92K
-Change in receivables
72.31%-110.74K
316.24%676.41K
--708.75K
---400K
47.13%-312.8K
-134.22%-591.62K
-953.54%-447.53K
---244.18K
569.96%1.73M
--52.43K
-Change in prepaid assets
-61.73%127.24K
-3,300.45%-1.28M
----
--332.51K
---37.5K
----
----
----
----
----
-Change in payables and accrued expense
-95.17%21.61K
216.88%2.27M
---111.94K
--447.42K
-183.16%-1.94M
616.02%2.34M
1,548.98%531.65K
--468.04K
884.71%326.56K
---36.69K
-Change in other current assets
4.00%48.06K
-3.60%189.51K
----
--46.21K
--196.58K
----
----
----
----
----
-Change in other current liabilities
17.88%-73.03K
57.53%-323.71K
----
---88.93K
---762.15K
----
----
----
----
----
-Change in other working capital
----
----
----
----
-94.30%-3.84M
0.00%-1.98M
0.00%-494.67K
---494.66K
2.56%-1.98M
---494.67K
Cash from discontinued investing activities
Operating cash flow
17.27%-2.41M
31.04%-10.54M
---3.64M
---2.91M
-174.01%-15.29M
-62.62%-5.58M
-67.45%-2.55M
---1.09M
49.00%-3.43M
---1.52M
Investing cash flow
Cash flow from continuing investing activities
96.13%-5.62K
32.69%-208.79K
-71.59K
-145.23K
-116.58%-310.2K
30.13%-143.22K
1.87%-52.04K
-30.27K
90.67%-204.99K
-53.03K
Net PPE purchase and sale
--0
40.58%-110.35K
---38.68K
---120.18K
-827.03%-185.71K
42.60%-20.03K
-80.48%-8.75K
---9.34K
98.28%-34.9K
---4.85K
Net intangibles purchase and sale
77.57%-5.62K
20.93%-98.44K
---32.91K
---25.05K
-1.05%-124.49K
27.57%-123.19K
10.15%-43.29K
---20.94K
-0.02%-170.09K
---48.18K
Cash from discontinued investing activities
Investing cash flow
96.13%-5.62K
32.69%-208.79K
---71.59K
---145.23K
-116.58%-310.2K
30.13%-143.22K
1.87%-52.04K
---30.27K
90.67%-204.99K
---53.03K
Financing cash flow
Cash flow from continuing financing activities
-76.42%932.56K
-54.32%8.52M
43.81K
3.95M
185.87%18.65M
90.22%6.53M
2,538.45%2.61M
2.36M
4.78%3.43M
-107.22K
Net issuance payments of debt
----
--0
----
----
-141.75%-2.61M
1,607.73%6.26M
2,538.45%2.61M
--2.36M
-406.39%-415.27K
---107.22K
Net common stock issuance
-98.63%19.77K
24.24%4.19M
---998.99K
--1.44M
1,081.97%3.37M
-92.69%285.11K
100.76%1
--0
24.24%3.9M
---131
Proceeds from stock option exercised by employees
-63.09%986.77K
-72.74%5.13M
--1.22M
--2.67M
--18.81M
--0
----
----
--0
----
Net other financing activities
53.46%-73.98K
12.64%-793.75K
--1
---158.97K
-4,193.96%-908.6K
60.28%-21.16K
--0
--0
---53.27K
--131
Cash from discontinued financing activities
Financing cash flow
-76.42%932.56K
-54.32%8.52M
--43.81K
--3.95M
185.87%18.65M
90.22%6.53M
2,538.45%2.61M
--2.36M
4.78%3.43M
---107.22K
Net cash flow
Beginning cash position
-48.78%2.46M
206.89%4.81M
--5.71M
--4.81M
109.45%1.57M
-21.80%748.02K
-36.18%1.55M
--287.99K
-85.66%956.5K
--2.43M
Current changes in cash
-265.04%-1.48M
-173.21%-2.23M
---3.67M
--897.76K
280.92%3.05M
487.67%800.89K
100.93%15.62K
--1.24M
96.35%-206.59K
---1.68M
Effect of exchange rate changes
----
-158.83%-112.17K
----
----
972.22%190.65K
1,040.30%17.78K
150.17%296
--18.76K
96.95%-1.89K
---590
End cash Position
-82.81%980.96K
-48.78%2.46M
--1.92M
--5.71M
206.89%4.81M
109.45%1.57M
109.45%1.57M
--1.55M
-21.80%748.02K
--748.02K
Free cash flow
21.01%-2.41M
31.32%-10.75M
---3.71M
---3.06M
-173.53%-15.66M
-57.40%-5.72M
-65.11%-2.6M
---1.12M
59.26%-3.64M
---1.57M
Currency Unit
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion with Explanatory Notes
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 17.27%-2.41M31.04%-10.54M-3.64M-2.91M-174.01%-15.29M-62.62%-5.58M-67.45%-2.55M-1.09M49.00%-3.43M-1.52M
Net income from continuing operations -423.20%-3.32M-349.68%-5.91M--288.49K---634.91K91.23%-1.31M-126.00%-14.98M-168.52%-4.52M---7.3M3.83%-6.63M---1.68M
Operating gains losses 99.64%-11.45K49.97%-7.97M---4.96M---3.17M-475.26%-15.94M224,465.20%4.25M45,841.19%271.05K--3.97M-97.40%1.89K--590
Depreciation and amortization -29.81%127.02K-17.75%633.01K--258.81K--180.97K-24.92%769.6K-4.66%1.03M-6.78%250.35K--249.31K18.88%1.08M--268.56K
Other non cash items -----89.40%717.41K--557.57K--231.54K96.85%6.77M1,081.49%3.44M2,692.96%1.92M--1.15M14.80%291.03K--68.81K
Change In working capital -96.11%13.13K122.96%1.54M--307.02K--337.21K-2,789.09%-6.7M-402.61%-232.08K14.28%-410.55K---270.81K104.23%76.69K---478.92K
-Change in receivables 72.31%-110.74K316.24%676.41K--708.75K---400K47.13%-312.8K-134.22%-591.62K-953.54%-447.53K---244.18K569.96%1.73M--52.43K
-Change in prepaid assets -61.73%127.24K-3,300.45%-1.28M------332.51K---37.5K--------------------
-Change in payables and accrued expense -95.17%21.61K216.88%2.27M---111.94K--447.42K-183.16%-1.94M616.02%2.34M1,548.98%531.65K--468.04K884.71%326.56K---36.69K
-Change in other current assets 4.00%48.06K-3.60%189.51K------46.21K--196.58K--------------------
-Change in other current liabilities 17.88%-73.03K57.53%-323.71K-------88.93K---762.15K--------------------
-Change in other working capital -----------------94.30%-3.84M0.00%-1.98M0.00%-494.67K---494.66K2.56%-1.98M---494.67K
Cash from discontinued investing activities
Operating cash flow 17.27%-2.41M31.04%-10.54M---3.64M---2.91M-174.01%-15.29M-62.62%-5.58M-67.45%-2.55M---1.09M49.00%-3.43M---1.52M
Investing cash flow
Cash flow from continuing investing activities 96.13%-5.62K32.69%-208.79K-71.59K-145.23K-116.58%-310.2K30.13%-143.22K1.87%-52.04K-30.27K90.67%-204.99K-53.03K
Net PPE purchase and sale --040.58%-110.35K---38.68K---120.18K-827.03%-185.71K42.60%-20.03K-80.48%-8.75K---9.34K98.28%-34.9K---4.85K
Net intangibles purchase and sale 77.57%-5.62K20.93%-98.44K---32.91K---25.05K-1.05%-124.49K27.57%-123.19K10.15%-43.29K---20.94K-0.02%-170.09K---48.18K
Cash from discontinued investing activities
Investing cash flow 96.13%-5.62K32.69%-208.79K---71.59K---145.23K-116.58%-310.2K30.13%-143.22K1.87%-52.04K---30.27K90.67%-204.99K---53.03K
Financing cash flow
Cash flow from continuing financing activities -76.42%932.56K-54.32%8.52M43.81K3.95M185.87%18.65M90.22%6.53M2,538.45%2.61M2.36M4.78%3.43M-107.22K
Net issuance payments of debt ------0---------141.75%-2.61M1,607.73%6.26M2,538.45%2.61M--2.36M-406.39%-415.27K---107.22K
Net common stock issuance -98.63%19.77K24.24%4.19M---998.99K--1.44M1,081.97%3.37M-92.69%285.11K100.76%1--024.24%3.9M---131
Proceeds from stock option exercised by employees -63.09%986.77K-72.74%5.13M--1.22M--2.67M--18.81M--0----------0----
Net other financing activities 53.46%-73.98K12.64%-793.75K--1---158.97K-4,193.96%-908.6K60.28%-21.16K--0--0---53.27K--131
Cash from discontinued financing activities
Financing cash flow -76.42%932.56K-54.32%8.52M--43.81K--3.95M185.87%18.65M90.22%6.53M2,538.45%2.61M--2.36M4.78%3.43M---107.22K
Net cash flow
Beginning cash position -48.78%2.46M206.89%4.81M--5.71M--4.81M109.45%1.57M-21.80%748.02K-36.18%1.55M--287.99K-85.66%956.5K--2.43M
Current changes in cash -265.04%-1.48M-173.21%-2.23M---3.67M--897.76K280.92%3.05M487.67%800.89K100.93%15.62K--1.24M96.35%-206.59K---1.68M
Effect of exchange rate changes -----158.83%-112.17K--------972.22%190.65K1,040.30%17.78K150.17%296--18.76K96.95%-1.89K---590
End cash Position -82.81%980.96K-48.78%2.46M--1.92M--5.71M206.89%4.81M109.45%1.57M109.45%1.57M--1.55M-21.80%748.02K--748.02K
Free cash flow 21.01%-2.41M31.32%-10.75M---3.71M---3.06M-173.53%-15.66M-57.40%-5.72M-65.11%-2.6M---1.12M59.26%-3.64M---1.57M
Currency Unit GBPGBPGBPGBPGBPGBPGBPGBPGBPGBP
Audit Opinions --Unqualified Opinion with Explanatory Notes----Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes----Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg